{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:26:49Z","timestamp":1758475609443},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T00:00:00Z","timestamp":1423699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s11060-015-1740-2","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T10:25:38Z","timestamp":1423650338000},"page":"451-459","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Deficiency of the protein-tyrosine phosphatase DEP-1\/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells"],"prefix":"10.1007","volume":"122","author":[{"given":"Astrid","family":"Petermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonn","family":"Stampnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Pachow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Kliese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank-D.","family":"B\u00f6hmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,12]]},"reference":[{"key":"1740_CR1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","volume":"99","author":"C Mawrin","year":"2010","unstructured":"Mawrin C, Perry A (2010) Pathological classification and molecular genetics of meningiomas. J Neurooncol 99:379\u2013391","journal-title":"J Neurooncol"},{"key":"1740_CR2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00432-014-1683-6","volume":"140","author":"A Wilisch-Neumann","year":"2014","unstructured":"Wilisch-Neumann A, Pachow D, Wallesch M, Petermann A, B\u00f6hmer FD, Kirches E, Mawrin C (2014) Re-evaluation of cytostatic therapies for meningiomas in vitro. J Cancer Res Clin Oncol 140:1343\u20131352","journal-title":"J Cancer Res Clin Oncol"},{"key":"1740_CR3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.226302","volume":"16","author":"M Kalamarides","year":"2002","unstructured":"Kalamarides M, Niwa-Kawakita M, Leblois H, Abramowski V, Perricaudet M, Janin A, Thomas G, Gutmann DH, Giovannini M (2002) Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev 16:1060\u20131065","journal-title":"Genes Dev"},{"key":"1740_CR4","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/onc.2010.609","volume":"30","author":"M Kalamarides","year":"2011","unstructured":"Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, Han ZY, Martinelli C, Lusis EA, Hegedus B, Gutmann DH, Giovannini M (2011) Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene 30:2333\u20132344","journal-title":"Oncogene"},{"key":"1740_CR5","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","volume":"16","author":"S Goutagny","year":"2010","unstructured":"Goutagny S, Yang HW, Zucman-Rossi J, Chan J, Dreyfuss JM, Park PJ, Black PM, Giovannini M, Carroll RS, Kalamarides M (2010) Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res 16:4155\u20134164","journal-title":"Clin Cancer Res"},{"key":"1740_CR6","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1038\/onc.2012.436","volume":"32","author":"M Peyre","year":"2013","unstructured":"Peyre M, Stemmer-Rachamimov A, Clermont-Taranchon E, Quentin S, El-Taraya N, Walczak C, Volk A, Niwa-Kawakita M, Karboul N, Giovannini M, Kalamarides M (2013) Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation. Oncogene 32:4264\u20134272","journal-title":"Oncogene"},{"key":"1740_CR7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL, Palescandolo E, Van Hummelen P, Ducar MD, Raza A, Sunkavalli A, Macconaill LE, Stemmer-Rachamimov AO, Louis DN, Hahn WC, Dunn IF, Beroukhim R (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45:285\u2013289","journal-title":"Nat Genet"},{"key":"1740_CR8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, Avsar T, Li J, Murray PB, Henegariu O, Yilmaz S, Gunel JM, Carrion-Grant G, Yilmaz B, Grady C, Tanrikulu B, Bakircioglu M, Kaymakcalan H, Caglayan AO, Sencar L, Ceyhun E, Atik AF, Bayri Y, Bai H, Kolb LE, Hebert RM, Omay SB, Mishra-Gorur K, Choi M, Overton JD, Holland EC, Mane S, State MW, Bilguvar K, Baehring JM, Gutin PH, Piepmeier JM, Vortmeyer A, Brennan CW, Pamir MN, Kilic T, Lifton RP, Noonan JP, Yasuno K, Gunel M (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080","journal-title":"Science"},{"key":"1740_CR9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3171\/jns.2001.95.5.0839","volume":"95","author":"AC Nordqvist","year":"2001","unstructured":"Nordqvist AC, Smurawa H, Mathiesen T (2001) Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. J Neurosurg 95:839\u2013844","journal-title":"J Neurosurg"},{"key":"1740_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/B:NEON.0000013474.01161.58","volume":"66","author":"M Okada","year":"2004","unstructured":"Okada M, Miyake K, Matsumoto Y, Kawai N, Kunishio K, Nagao S (2004) Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. J Neurooncol 66:29\u201337","journal-title":"J Neurooncol"},{"key":"1740_CR11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/cncr.22130","volume":"107","author":"AF Okuducu","year":"2006","unstructured":"Okuducu AF, Zils U, Michaelis SA, Mawrin C, von Deimling A (2006) Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9. Cancer 107:1365\u20131372","journal-title":"Cancer"},{"key":"1740_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-010-0312-8","volume":"102","author":"V Barresi","year":"2011","unstructured":"Barresi V, Vitarelli E, Tuccari G, Barresi G (2011) MMP-9 expression in meningiomas: a prognostic marker for recurrence risk? J Neurooncol 102:189\u2013196","journal-title":"J Neurooncol"},{"key":"1740_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1750-3639.2010.00464.x","volume":"21","author":"A Petermann","year":"2011","unstructured":"Petermann A, Haase D, Wetzel A, Balavenkatraman KK, Tenev T, Guhrs KH, Friedrich S, Nakamura M, Mawrin C, B\u00f6hmer FD (2011) Loss of the protein-tyrosine phosphatase DEP-1\/PTPRJ drives meningioma cell motility. Brain Pathol 21:405\u2013418","journal-title":"Brain Pathol"},{"key":"1740_CR14","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1158\/0008-5472.CAN-05-0240","volume":"65","author":"IC Cuevas","year":"2005","unstructured":"Cuevas IC, Slocum AL, Jun P, Costello JF, Bollen AW, Riggins GJ, McDermott MW, Lal A (2005) Meningioma transcript profiles reveal deregulated Notch signaling pathway. Cancer Res 65:5070\u20135075","journal-title":"Cancer Res"},{"key":"1740_CR15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3171\/jns.1997.87.2.0315","volume":"87","author":"RS Carroll","year":"1997","unstructured":"Carroll RS, Black PM, Zhang J, Kirsch M, Percec I, Lau N, Guha A (1997) Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 87:315\u2013323","journal-title":"J Neurosurg"},{"key":"1740_CR16","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.87.15.5710","volume":"87","author":"JA Takahashi","year":"1990","unstructured":"Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M (1990) Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci U S A 87:5710\u20135714","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1740_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-5793(98)01034-5","volume":"435","author":"M Bond","year":"1998","unstructured":"Bond M, Fabunmi RP, Baker AH, Newby AC (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 435:29\u201334","journal-title":"FEBS Lett"},{"key":"1740_CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1054\/bjoc.1999.0876","volume":"82","author":"HK Rooprai","year":"2000","unstructured":"Rooprai HK, Rucklidge GJ, Panou C, Pilkington GJ (2000) The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 82:52\u201355","journal-title":"Br J Cancer"},{"key":"1740_CR19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.cellsig.2009.01.034","volume":"21","author":"S Kim","year":"2009","unstructured":"Kim S, Choi JH, Lim HI, Lee SK, Kim WW, Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH (2009) EGF-induced MMP-9 expression is mediated by the JAK3\/ERK pathway, but not by the JAK3\/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell Signal 21:892\u2013898","journal-title":"Cell Signal"},{"key":"1740_CR20","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.cub.2009.09.048","volume":"19","author":"G Tarcic","year":"2009","unstructured":"Tarcic G, Boguslavsky SK, Wakim J, Kiuchi T, Liu A, Reinitz F, Nathanson D, Takahashi T, Mischel PS, Ng T, Yarden Y (2009) An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr Biol 19:1788\u20131798","journal-title":"Curr Biol"},{"key":"1740_CR21","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2011-09-381012","volume":"119","author":"C Giampietro","year":"2012","unstructured":"Giampietro C, Taddei A, Corada M, Sarra-Ferraris GM, Alcalay M, Cavallaro U, Orsenigo F, Lampugnani MG, Dejana E (2012) Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood 119:2159\u20132170","journal-title":"Blood"},{"key":"1740_CR22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/BJ20071317","volume":"413","author":"N Tsuboi","year":"2008","unstructured":"Tsuboi N, Utsunomiya T, Roberts RL, Ito H, Takahashi K, Noda M, Takahashi T (2008) The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J 413:193\u2013200","journal-title":"Biochem J"},{"key":"1740_CR23","doi-asserted-by":"crossref","unstructured":"Sacco F, Tinti M, Palma A, Ferrari E, Nardozza AP, Hooft van Huijsduijnen R, Takahashi T, Castagnoli L, Cesareni G (2009) Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1\/2 kinases. J Biol Chem 284:22048\u201322058","DOI":"10.1074\/jbc.M109.002758"},{"key":"1740_CR24","doi-asserted-by":"crossref","first-page":"23460","DOI":"10.1016\/S0021-9258(19)49485-4","volume":"268","author":"H Sato","year":"1993","unstructured":"Sato H, Kita M, Seiki M (1993) v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem 268:23460\u201323468","journal-title":"J Biol Chem"},{"key":"1740_CR25","first-page":"395","volume":"8","author":"H Sato","year":"1993","unstructured":"Sato H, Seiki M (1993) Regulatory mechanism of 92\u00a0kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395\u2013405","journal-title":"Oncogene"},{"key":"1740_CR26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0008-6363(01)00220-6","volume":"50","author":"M Bond","year":"2001","unstructured":"Bond M, Chase AJ, Baker AH, Newby AC (2001) Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50:556\u2013565","journal-title":"Cardiovasc Res"},{"key":"1740_CR27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/sj.onc.1201012","volume":"14","author":"BP Himelstein","year":"1997","unstructured":"Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ (1997) Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14:1995\u20131998","journal-title":"Oncogene"},{"key":"1740_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1006576305405","volume":"16","author":"BP Himelstein","year":"1998","unstructured":"Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ (1998) Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin Exp Metastasis 16:169\u2013177","journal-title":"Clin Exp Metastasis"},{"issue":"Pt 1","key":"1740_CR29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/bj3150335","volume":"315","author":"RP Fabunmi","year":"1996","unstructured":"Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC (1996) Divergent regulation by growth factors and cytokines of 95\u00a0kDa and 72\u00a0kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 315(Pt 1):335\u2013342","journal-title":"Biochem J"},{"key":"1740_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(94)90256-9","volume":"170","author":"E Boyle-Walsh","year":"1994","unstructured":"Boyle-Walsh E, Hashim IA, Speirs V, Fraser WD, White MC (1994) Interleukin-6 (IL-6) production and cell growth of cultured human ameningiomas:-interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitro. Neurosci Lett 170:129\u2013132","journal-title":"Neurosci Lett"},{"key":"1740_CR31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ijc.10207","volume":"98","author":"J Held-Feindt","year":"2002","unstructured":"Held-Feindt J, Mentlein R (2002) CD70\/CD27 ligand, a member of the TNF family, is expressed in human brain tumors. Int J Cancer 98:352\u2013356","journal-title":"Int J Cancer"},{"key":"1740_CR32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7150\/ijms.5185","volume":"10","author":"Q Huang","year":"2013","unstructured":"Huang Q, Zhao SL, Tian XY, Li B, Li Z (2013) Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma. Int J Med Sci 10:276\u2013285","journal-title":"Int J Med Sci"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1740-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1740-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1740-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:26:57Z","timestamp":1651220817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1740-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,12]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1740-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,12]]}}}